Glooko
Signal active
Investment Firm
Overview
Glooko develops a remote patient-monitoring platform to identify at-risk patients with diabetes. It integrates with diabetes devices, fitness wearables, and activity trackers to allow data capture and provide reports and analytics that aim to drive behavior change and outcomes.
Highlights
Founded
2010
Industry
SaaS
Employees
101-250
Investment
1
Lead Investment
0
Exits
undefined
Stages
Early Stage Venture
Investor Type
N/A
Location
United States, North America
Contact Information
Social
Profile Resume
Glooko, established in 2010 and headquartered in United States, North America., specializes in Early Stage Venture investments across Financial Services, Venture Capital, Finance, FinTech, Impact Investing, Asset Management. Their recent investments include Social Capital. The highest investment round they participated in was $168.0M. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.
Investment portfolio
Glooko has made 1 investments. Their most recent investment was on Jan 08, 2014, when Glooko raised $7.0M.
investments
1
Diversity investments
0
Lead investments
0
Number of exits
undefined
Investments
1
| Annouced Date | Organization Name | Industry | Money Raised |
|---|---|---|---|
| Jan 08, 2014 | Glooko | SaaS | 7.0M |
GlookoExits
0
Funding Timeline
Funding rounds
1
Investors
24
Funds
0
Funding Rounds
1
Glooko has raised 1 rounds. Their latest funding was raised on Jan 08, 2014 from a Series A - Glooko round.
| Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
|---|---|---|---|---|
| Jan 08, 2014 | Series A - Glooko | - | 7.0M | - |
Investors
28
Glooko is funded by 28 investor(s). Canaan Partners and Novo Nordisk Kantor are the most recent investors.
| Investor Name | Lead Investor | Funding Round | Money Raised |
|---|---|---|---|
Georgian | No | Series D - Glooko | 30.0M |
Insulet | No | Series D - Glooko | 30.0M |
Novo Nordisk | No | Series D - Glooko | 30.0M |
Canaan Partners | No | Series D - Glooko | 30.0M |
Insulet
Novo NordiskFund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
| Annouced Date | Fund Name | Money Raised |
|---|---|---|
| May 10, 2013 | OTPPLESS | 1.0M |
| May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries
Recent Activity
There is no recent news or activity for this profile.